Protein Profiles and Novel Molecular Biomarkers of Schizophrenia Based on 4D-DIA Proteomics
Journal of Proteome Research · 05.07.2024 · 23 (7) · 2376-2385
DOI: 10.1021/acs.jproteome.4c00040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 10.06.2024. Verfasst von Hui-Ping Shen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Shaoxing Seventh People's Hospital, Shaoxing 312000, China. Hauptthemen laut MEDLINE: Schizophrenia, Biomarkers, Proteomics, Profilins. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Shaoxing Seventh People's Hospital, Zhejiang Medical and Health Science and Technology project.
Abstract (Originalsprache)
Schizophrenia is a severe psychological disorder. The current diagnosis mainly relies on clinical symptoms and lacks laboratory evidence, which makes it very difficult to make an accurate diagnosis especially at an early stage. Plasma protein profiles of schizophrenia patients were obtained and compared with healthy controls using 4D-DIA proteomics technology. Furthermore, 79 DEPs were identified between schizophrenia and healthy controls. GO functional analysis indicated that DEPs were predominantly associated with responses to toxic substances and platelet aggregation, suggesting the presence of metabolic and immune dysregulation in patients with schizophrenia. KEGG pathway enrichment analysis revealed that DEPs were primarily enriched in the chemokine signaling pathway and cytokine receptor interactions. A diagnostic model was ultimately established, comprising three proteins, namely, PFN1, GAPDH and ACTBL2. This model demonstrated an AUC value of 0.972, indicating its effectiveness in accurately identifying schizophrenia. PFN1, GAPDH and ACTBL2 exhibit potential as biomarkers for the early detection of schizophrenia. The findings of our studies provide novel insights into the laboratory-based diagnosis of schizophrenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Shaoxing Seventh People's Hospital, Shaoxing 312000, China.
- Major Disease Biomarker Research Laboratory, School of Basic Medical Science, Henan University, Kaifeng 475004, China.
- Institute of Cell Biology, Zhejiang University School of Medicine, Hangzhou 310058, China.
ORCID-Profile: Xiaotao Dong
Förderung
- Shaoxing Seventh People's Hospital
- Zhejiang Medical and Health Science and Technology project
Zitieren
APA
Shen, H. P., Dong, X., Li, Z. B., Wu, J. Z., Zheng, C. M., Hu, X. J., Qian, C., Wang, S. P., Zhao, Y. L., & Li, J. C. (2024). Protein Profiles and Novel Molecular Biomarkers of Schizophrenia Based on 4D-DIA Proteomics. Journal of Proteome Research, 23(7), 2376-2385. https://doi.org/10.1021/acs.jproteome.4c00040
Vancouver
Shen HP, Dong X, Li ZB, Wu JZ, Zheng CM, Hu XJ, et al. Protein Profiles and Novel Molecular Biomarkers of Schizophrenia Based on 4D-DIA Proteomics. Journal of Proteome Research. 2024;23(7):2376-2385. doi:10.1021/acs.jproteome.4c00040
BibTeX
@article{Shen2024,
author = {Shen, Hui-Ping and Dong, Xiaotao and Li, Zhi-Bin and Wu, Jing-Zhu and Zheng, Chun-Mei and Hu, Xie-Jun and Qian, Chao and Wang, Sheng-Pang and Zhao, Yu-Long and Li, Ji-Cheng},
title = {Protein Profiles and Novel Molecular Biomarkers of Schizophrenia Based on 4D-DIA Proteomics},
journal = {Journal of Proteome Research},
year = {2024},
volume = {23},
number = {7},
pages = {2376--2385},
doi = {10.1021/acs.jproteome.4c00040}
}
EUVIMED